No prime time yet for checkpoint inhibitors in localised head and neck squamous cell carcinoma

被引：2
|
作者：
Voortman, Jens [1 ]
机构：
[1] Vrije Univ Amsterdam, Canc Ctr Amsterdam, Dept Med Oncol, Amsterdam UMC, NL-1081 HV Amsterdam, Netherlands
来源：
LANCET ONCOLOGY | 2024年 / 25卷 / 05期
关键词：
RECURRENT;
D O I：
10.1016/S1470-2045(24)00197-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：533 / 534
页数：2
相关论文
共 50 条
  • [1] Immune Checkpoint Inhibitors for Head and Neck Squamous Cell Carcinoma
    Chang, Hui-Chin
    Gau, Shuo-Yan
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2025, 151 (02)
  • [2] Immune Checkpoint Inhibitors for Head and Neck Squamous Cell Carcinoma-Reply
    Mastrolonardo, Eric V.
    Llerena, Pablo
    Curry, Joseph M.
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2025, 151 (02)
  • [3] Current and Future Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma
    Park, Jong Chul
    Krishnakumar, Hari N.
    Saladi, Srinivas Vinod
    CURRENT ONCOLOGY, 2022, 29 (06) : 4185 - 4198
  • [4] Immune checkpoint inhibitors for head and neck squamous cell carcinoma: Current landscape and future directions
    Kao, Hsiang-Fong
    Lou, Pei-Jen
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2019, 41 : 4 - 18
  • [5] Outcomes Among Patients With Mucosal Head and Neck Squamous Cell Carcinoma Treated With Checkpoint Inhibitors
    Hobday, Sara B.
    Brody, Robert M.
    Kriegsman, Barry
    Basu, Devraj
    Newman, Jason
    Cohen, Roger B.
    Lukens, J. Nicholas
    Singh, Aditi
    D'Avella, Christopher A.
    Sun, Lova
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2022, 148 (10) : 918 - 926
  • [6] Immune biomarkers of response to immune-checkpoint inhibitors in head and neck squamous cell carcinoma
    Oliva, M.
    Spreafico, A.
    Taberna, M.
    Alemany, L.
    Coburn, B.
    Mesia, R.
    Siu, L. L.
    ANNALS OF ONCOLOGY, 2019, 30 (01) : 57 - 67
  • [7] Genomic correlates of response to immune checkpoint inhibitors in advanced head and neck squamous cell carcinoma
    Patel, Nisarg A.
    Vokes, Natalie, I
    Elmarakeby, Haitham
    Hanna, Glenn J.
    Van Allen, Eliezer M.
    CANCER RESEARCH, 2020, 80 (16)
  • [8] Hypothyroidism in Head and Neck Squamous Cell Carcinoma Patients Receiving Radiotherapy With or Without Immune Checkpoint Inhibitors
    Leddon, Jennifer L.
    Chirra, Martina
    Frankart, Andrew J.
    Agrawal, Arushi
    Roof, Logan
    Trotier, Danny
    Shaikh, Hira
    Stone, Timothy
    Jandarov, Roman
    Takiar, Vinita
    Wise-Draper, Trisha M.
    LARYNGOSCOPE, 2021, 131 (07): : E2413 - E2419
  • [9] Clinical implications of hyperprogression with immune checkpoint inhibitors in patients with head and neck squamous cell carcinoma (HNSCC).
    Economopoulou, Panagiota
    Spathas, Nikolaos Spiridon
    Papaxoinis, George
    Anastasiou, Maria
    Gkotzamanidou, Maria
    Kotsantis, Ioannis
    Gavrielatou, Niki
    Oikonomopoulos, Nikolaos
    Kirodimos, Euthymios
    Vagia, Elena Mihal
    Kavourakis, George
    Psyrri, Amanda
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [10] Immune checkpoint pathways in immunotherapy for head and neck squamous cell carcinoma
    Zi Mei
    Junwen Huang
    Bin Qiao
    Alfred King-yin Lam
    International Journal of Oral Science, 2020, 12
12345